MDLZ Stock Analysis: Mondelez International | NASDAQ
Confectioners | NASDAQ, USA | Market Cap: 81.084m USD | 12M Return: 6% | US6092071058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 499M
EPS Trend: -75.3%
Qual. Beats: 2
Rev. Trend: 94.0%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Mondelez International is a global snack food and beverage company that manufactures, markets, and sells products across Latin America, North America, Asia, the Middle East, Africa, and Europe. Its product portfolio spans biscuits and baked snacks (such as cookies, crackers, salted snacks, snack bars, and cakes), chocolates, gums and candies, and a range of cheese, grocery, and powdered beverage items. The company markets globally recognized brands including Oreo, Ritz, LU, CLIF Bar, Cadbury Dairy Milk, Milka, and Toblerone.
The company distributes its products through a broad mix of retail channels, including supermarket chains, wholesalers, supercenters, club stores, convenience stores, drug stores, and e-retail platforms, using a combination of direct store delivery, company-owned warehouses, third-party distributors, and independent sales offices. It also sells directly to consumers through retailer digital platforms, its own websites, and social media. Mondelez was formerly known as Kraft Foods Inc. before adopting its current name in October 2012; it was incorporated in 2000 and is headquartered in Chicago, Illinois.
Mondelez operates within the Consumer Staples sector (Packaged Foods & Meats), a defensive industry category whose products tend to see stable demand across economic cycles. As a large-cap U.S.-listed company, it is widely held by institutional investors and benefits from a diversified geographic footprint that reduces reliance on any single regional market.
- Cocoa and input cost inflation pressures chocolate margins
- Emerging market FX headwinds weigh on Latin America revenue
- Pricing actions offset volume softness in developed markets
| Net Income: 3.52b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: -21.81% < 20% (prev -19.22%; Δ -2.59% < -1%) |
| CFO/TA 0.06 > 3% & CFO 4.44b > Net Income 3.52b |
| Net Debt (20.9b) to EBITDA (6.18b): 3.39 < 3 |
| Current Ratio: 0.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.29b) vs 12m ago -0.54% < -2% |
| Gross Margin: 31.15% > 18% (prev 32.55%; Δ -1.40% > 0.5%) |
| Asset Turnover: 55.78% > 50% (prev 52.25%; Δ 3.53% > 0%) |
| Interest Coverage Ratio: 7.95 > 6 (EBIT TTM 4.79b / Interest Expense TTM 603.0m) |
| A: -0.12 (Total Current Assets 12.9b - Total Current Liabilities 21.6b) / Total Assets 71.2b |
| B: 0.52 (Retained Earnings 37.2b / Total Assets 71.2b) |
| C: 0.07 (EBIT TTM 4.79b / Avg Total Assets 71.1b) |
| D: 0.60 (Book Value of Equity 26.6b / Total Liabilities 44.6b) |
| Altman-Z'' = 1.99 = BBB |
| DSRI: 1.01 (Receivables 5.01b/4.63b, Revenue 39.7b/37.1b) |
| GMI: 1.05 (GM 32.55% / 31.15%) |
| AQI: 0.99 (AQ_t 0.66 / AQ_t-1 0.66) |
| SGI: 1.07 (Revenue 39.7b / 37.1b) |
| TATA: -0.01 (NI 3.52b - CFO 4.44b) / TA 71.2b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of August 22, 2026, the stock is trading at USD 64.45 with a total of 5,800,049 shares traded. Over the past week, the price has changed by +1.32%, over one month by +7.67%, over three months by +5.68% and over the past year by +5.96%.
Current recommended Stop Loss: 61.10 (which is 5.2% or 2.3 ATR below the current price).
Mondelez International has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy MDLZ.
- StrongBuy: 11
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 69.1 | 7.3% |
P/E Trailing = 38.0419
P/E Forward = 20.4918
P/S = 2.0437
P/B = 2.948
P/EG = 1.0187
Revenue TTM = 39.7b USD
EBIT TTM = 4.79b USD
EBITDA TTM = 6.18b USD
Long Term Debt = 17.2b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.99b USD (from shortTermDebt, last quarter)
Debt = 22.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 598.0m
Net Debt = 20.9b USD (calculated: Debt 22.7b - CCE 1.72b)
Enterprise Value = 102b USD (81.1b + Debt 22.7b - CCE 1.72b)
Interest Coverage Ratio = 7.95 (Ebit TTM 4.79b / Interest Expense TTM 603.0m)
EV/FCF = 33.07x (Enterprise Value 102b / FCF TTM 3.08b)
FCF Yield = 3.02% (FCF TTM 3.08b / Enterprise Value 102b)
FCF Margin = 7.78% (FCF TTM 3.08b / Revenue TTM 39.7b)
Net Margin = 8.86% (Net Income TTM 3.52b / Revenue TTM 39.7b)
Gross Margin = 31.15% ((Revenue TTM 39.7b - Cost of Revenue TTM 27.3b) / Revenue TTM)
Gross Margin QoQ = 42.61% (prev 27.81%)
Tobins Q-Ratio = 1.43 (Enterprise Value 102b / Total Assets 71.2b)
Interest Expense / Debt = 2.66% (Interest Expense 603.0m / Debt 22.7b)
Taxrate = 21.98% (990.0m / 4.50b)
NOPAT = 3.74b (EBIT 4.79b * (1 - 21.98%))
Current Ratio = 0.60 (Total Current Assets 12.9b / Total Current Liabilities 21.6b)
Debt / Equity = 0.85 (Debt 22.7b / totalStockholderEquity, last quarter 26.6b)
Debt / EBITDA = 3.39 (Net Debt 20.9b / EBITDA 6.18b)
Debt / FCF = 6.79 (Net Debt 20.9b / FCF TTM 3.08b)
Total Stockholder Equity = 26.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.94% (Net Income 3.52b / Total Assets 71.2b)
RoE = 13.47% (Net Income TTM 3.52b / Total Stockholder Equity 26.1b)
RoCE = 11.06% (EBIT 4.79b / Capital Employed (Equity 26.1b + L.T.Debt 17.2b))
RoIC = 7.06% (NOPAT 3.74b / Invested Capital 52.9b)
WACC = 4.31% (E(81.1b)/V(104b) * Re(4.93%) + D(22.7b)/V(104b) * Rd(2.66%) * (1-Tc(0.22)))
Discount Rate = 4.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.39 | Cagr: -2.09%
[DCF] Terminal Value 76.41% ; FCFF base≈3.00b ; Y1≈3.20b ; Y5≈3.85b
[DCF] Fair Price = 29.87 (EV 59.1b - Net Debt 20.9b = Equity 38.1b / Shares 1.28b; r=8.35% [WACC [floored]]; 5y FCF grow 7.83% → 2.50% )
EPS Correlation: -75.26 | EPS CAGR: -6.94% | SUE: 1.36 | # QB: 2
Revenue Correlation: 93.98 | Revenue CAGR: 3.99% | SUE: 1.00 | # QB: 3
EPS current Quarter (2026-09-30): EPS=0.72 | Chg30d=-11.10% | Revisions=-77% | Analysts=17
EPS current Year (2026-12-31): EPS=3.05 | Chg30d=-0.17% | Revisions=-46% | GrowthEPS=+4.3% | GrowthRev=+4.1%
EPS next Year (2027-12-31): EPS=3.36 | Chg30d=-0.46% | Revisions=-55% | GrowthEPS=+10.3% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: -71% (up=3, down=25)